Metabolic Collaboration and Licensing Deals 2019-2024

Metabolic Collaboration and Licensing Deals provides the reader with the following key benefits:

• Understand deal trends since 2019
• Browse metabolic collaboration and licensing deals
• Benchmark analysis – identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in metabolic dealmaking

2.1. Introduction

2.2. Metabolic partnering over the years     

2.3. Metabolic partnering by deal type

2.4. Metabolic partnering by industry sector

2.5. Metabolic partnering by stage of development

2.6. Metabolic partnering by technology type

2.7. Metabolic partnering by therapeutic indication

Chapter 3 – Financial deal terms for metabolic partnering

3.1. Introduction

3.2. Disclosed financials terms for metabolic partnering

3.3. Metabolic partnering headline values

3.4. Metabolic deal upfront payments

3.5. Metabolic deal milestone payments

3.6. Metabolic royalty rates

Chapter 4 – Leading metabolic deals and dealmakers

4.1. Introduction

4.2. Most active in metabolic partnering

4.3. List of most active dealmakers in metabolic    

4.4. Top metabolic deals by value

Chapter 5 – Metabolic contract document directory

5.1. Introduction

5.2. Metabolic partnering deals where contract document available

Chapter 6 – Metabolic dealmaking by therapeutic target

6.1. Introduction

6.2. Deals by metabolic therapeutic target

Deal directory

Deal directory – Metabolic deals by company A-Z 2019 to 2024

Deal directory – Metabolic deals by technology type 2019 to 2024

Deal type definitions

About Biopharma Research Ltd

Current Partnering

Current Agreements

Recent report titles from Current Partnering

Table of figures

Figure 1: Metabolic partnering since 2019

Figure 2: Metabolic partnering by deal type since 2019

Figure 3: Metabolic partnering by industry sector since 2019

Figure 4: Metabolic partnering by stage of development since 2019

Figure 5: Metabolic partnering by technology type since 2019

Figure 6: Metabolic partnering by indication since 2019

Figure 7: Metabolic deals with a headline value

Figure 8: Metabolic deals with upfront payment values

Figure 9: Metabolic deals with milestone payment

Figure 10: Metabolic deals with royalty rates

Figure 11: Active metabolic dealmaking activity since 2019

Figure 12: Top metabolic deals by value since 2019

Pricing options

• $3,995: single-user (encrypted file - one user/device)
• $5,995: multi-user (encrypted file - up to 5 users/devices)
• $9,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

Our guarantee

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by Evalon.

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

4P-Pharma, 23andMe, 180 Life Sciences, Abbisko Therapeutics, Abbott Laboratories, AbCellera Biologics, Abeona Therapeutics, AcelaBio, Acenzia, Aceragen, Acerus, Acuitas Therapeutics, Adaptive Phage Therapeutics, Adhera Therapeutics, Advanz Pharma, AdventHealth, Aeglea BioTherapeutics, AEterna Zentaris, Aevi Genomic Medicine, AgBiome, AgeX Therapeutics, AiCuris, Ajinomoto, Akcea Therapeutics, Akero Therapeutics, Albert Einstein College of Medicine, Albireo, Alexion Pharmaceuticals, Aligos Therapeutics, Alimentiv, AliveCor, Allele Biotechnology and Pharmaceuticals, AllerGenis, Allevi 3D, Almelo, Alnylam Pharmaceuticals, ALR Technologies, ALTuCELL, Amarna Therapeutics, Amazentis, Ambiopharm, AM Chemicals, A Menarini Diagnostics, American Association for the Study of Liver Diseases, American Diabetes Association, Amgen, Amicus Therapeutics, AmideBio, Amolyt Pharma, AMRA Medical, Amyris, Anagram Therapeutics, Angers University, Anivive Lifesciences, Anji Pharma, Antares Pharma, Apellis Pharmaceuticals, Apollon Formularies, Applied DNA Sciences, Applied Therapeutics, APR Applied Pharma Research, Arbor Biotechnologies, Arch Biopartners, Archer Daniels Midland Company, Arecor, Argon Medical Devices, Arjuna Naturals, Arrowhead Pharmaceuticals, Arzeda, Ascendis Pharma, Ascensia Diabetes Care, Ascletis, Asklepios Biopharmaceutical, Aspect Biosystems, Astellas Pharma, Astex Pharmaceuticals, AstraZeneca, ATUM, Avicanna, Avrobio, Axcella, AXIM Biotechnologies, Axovant Gene Therapies, Aytu BioPharma, Baliopharm, BaoDao Feed, Basepaws, Bavarian Brewing & Beverage Institute, Baxter International, Bayer, BCD Bioscience, Beam Therapeutics, Beijing University of Chinese Medicine, Bened Biomedical, Benuvia Therapeutics, Berg, Better Therapeutics, Beyond Type 1, Bigfoot Biomedical, Bill and Melinda Gates Foundation, Bioadaptives, biOasis Technologies, Biocon, BIOCORP, Biodexa Pharmaceuticals, BioHarvest Sciences, BIOHM Health Inc, BioLinQ, Biolojic Design, BioMed X Innovation Center, BioPep, Biosidus, Bird Foundation, Boehringer Ingelheim, Bond Pet Foods, Boston Scientific, BPGbio, Bracco Imaging, Brand Institute, Bridge Biotherapeutics, Brigham and Women's Hospital, BrightInsight, Brightseed, Broad Institute, Bruker, Bruno Farmaceutici, Bunker Pflanzenextrakte, c-LEcta, Cambrooke Therapeutics, CamDiab, CAMP4 Therapeutics, Can-Fite BioPharma, CANbridge Pharmaceuticals, Cantex Pharmaceuticals, Capillary Biomedical, Capitainer, Cardiff University, Cardinal Health, Cardiovascular Solutions of Central Mississippi, CASI Pharmaceuticals, Catalent, Cellarity, CELLINK, Celloram, Centene, Center for Genomic Regulation, Centogene, Centre for Commercialization of Regenerative Medicine (CCRM), Centrus Health Clinics, Century Therapeutics, Chiesi Farmaceutici, Children's Hospital at Montefiore, Children's Hospital Boston, ChromaDex, Cibus Global, Citrine Medicine, Civica Rx, CJ CheilJedang, Clarus Therapeutics, Clinigen, CN Bio, Code Biotherapeutics, Codexis, Columbia University, Companion Medical, Conatus Pharmaceuticals, Consilient Health, Cooper Aerobics, Corvium, Cosmos, COUR Pharmaceutical, Covance, Creative Medical Technologies, Crinetics, CRISPR Therapeutics, Critical Path Institute (C-Path), Crossject, Cukierman & Co Life Sciences, Cure Genetics, Cycle Pharmaceuticals, CymaBay Therapeutics, Cystic Fibrosis Foundation, Cytoo, Deargen, Decode Health, Defense Health Agency (US), DEKA Research and Development, Delta 4, Delve Health, Dewpoint Therapeutics, DexCom, Diabeloop, Diabetes Research Connection, Diabetes Research Institute, Diabetes Singapore, Diamyd Medical, Dicerna Pharmaceuticals, DigiLab, Diomics, Diurnal, DKSH, DNAnexus, DolCas Biotech, Dong-A ST, DreaMed Diabetes, DSM, Duke University, DuPont Pharmaceuticals, Dyadic International, Dyno Therapeutics, EatLove, Eccogene, Echosens, ECMOHO, EffRx Pharmaceuticals, Ei.Ventures, EirGen Pharma, Elanco, Elcelyx Therapeutics, Eleven Biotherapeutics, Eli Lilly, ELNA Medical, Elo Life Systems, Emmyon, Enable Biosciences, ENDRA Life Sciences, Engitix, Engrail Therapeutics, Entera Bio, Enzyvant Science, Epitomee Medical, Eracal Therapeutics, Eton Pharmaceuticals, European Union Regional Development Fund, European Wellness Biomedical Group, EVA Pharma, EverlyWell, Eversana, Evgen Pharma, Evidation Health, Evo Foods, EVOQ Therapeutics, Evotec, Evozyne, Ewopharma, Fermbox Bio, First Wave Bio, FitBit, Flagship Biosciences, Fondazione San Raffaele, Fondazione Telethon, Fonterra, Food and Drug Administration (FDA), Foundation for Diabetes Research, FUJIFILM Cellular Dynamics, Fundacion Progreso y Salud, G3 Therapeutics, G42 Healthcare, Gain Therapeutics, Galapagos, Galectin Therapeutics, Galmed Pharmaceuticals, Gan & Lee, Gannex Pharma, GATC Health, GC Pharma, GE Healthcare, Genentech, General Automation Lab Technologies, Generation Bio, Generex Biotechnology, Genethon, Genetron Health, Genevant Sciences, Genfit, Genome Quebec, Genomma Lab Internacional, Genprex, George Clinical, Gilead Sciences, Ginkgo BioWorks, Glenmark Pharmaceuticals, Global Liver Institute, Glooko, GlucoModicum, Glympse Bio, Glytec, Goldfinch Bio, GoodRx, Graviton Bioscience, Group K Diagnostics, GSK, Hamilton Company, Hanmi Pharmaceutical, Hansa Biopharma, Harbin Pharmaceutical Group, Harvard Medical School, Haselmeier, Hatch Medical, Health2Sync, Healthimation, Health Network Laboratories, Healthy.io, Healthy Grain, HemoShear, Hepalys Pharma, HepaTx, Hepion Pharmaceuticals, HepQuant, Hill's Pet Nutrition, HistoIndex, HitGen, Horizon Discovery, Horizon Therapeutics, Humacyte, I-mab, iECURE, Imagine Pharmaceuticals, Imaware, Immedica, Immusoft, Imperial College London, Indiana University, Ingredion, Innovate UK, Innovation Zed, Innovent Biologics, Inserm, Insilico Medicine, Insitro, InSphero, Institute of Endocrinology, Metabolism, and Reproduction, Institut National Recherche Agronomique, Insulet, Intercept Pharmaceuticals, International Diabetes Federation (IDF), International Niemann-Pick Disease Registry, Inventiva, Invitae, Ionis Pharmaceuticals, Ipsen, IQVIA, Ironwood Pharmaceuticals, iSage Rx, Itochu, iTolerance, Jackson Laboratory, Jadeite Medicines, Janssen Pharmaceuticals, Janssen Research & Development, Janssen Therapeutics, Jasper Therapeutics, JCR Pharmaceuticals, Jennewein Biotechnologie, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Jinggangshan University, Johns Hopkins Medicine (JHM), Johns Hopkins University, Journey Medical, Jumpcan Pharmaceutical, Juntendo University, Juvenescence, Juvenile Diabetes Research Foundation, Kadimastem, Kahn-Sagol-Maccabi, Kaken Pharmaceutical, Kaleido Biosciences, Kalsec, Katana Pharmaceuticals, Klue, Know Labs, Kore, Kyowa Hakko Kirin, Labcyte, Laboratory Corporation of America, Lannett, Lark Technologies, Launch Therapeutics, Leona M and Harry B Helmsley Charitable Trust, Lexicon Pharmaceuticals, LG Life Sciences, Life Genomics AB, LifeOmic, LifeScan, Lipigon Pharmaceuticals, Lipocine, Livongo Health, LogicBio Therapeutics, Lonza, LUCA Science, Lumen Biomedical, Luminex, Lumos Pharma, Lurie Children's Hospital of Chicago, LyGenesis, Lygos, LY Research, Lysando, Lysogene, mAbXience, Mammoth Biosciences, Mandos, MannKind Biopharmaceuticals, Massachusetts General Hospital, Massachusetts Institute of Technology, Mass General Brigham, Max Biopharma, Mayo Clinic, Maze Therapeutics, McGill University, McQuade Center for Strategic Research and Development, Meatable, MEDIAN Technologies, Medical College of Wisconsin, Medical University of South Carolina, MediciNova, Medicox, MedImmune, Medipal Holdings, Medison Pharma, Medtronic, Meitheal Pharmaceuticals, Melior Pharmaceuticals, Merck and Co, Merck KGaA, Merieux NutriSciences, Merz, Mesh Bio, Metaba, Meta Healthcare, MetaSight Diagnostics, MiNA Therapeutics, Minerva Foods, Minovia Therapeutics, Miromatrix Medical, Mirum Pharmaceuticals, Mission Bio, Mitobridge, MJH Life Sciences, Moderna, Modular Medical, Mount Sinai Health System, mPulse Mobile, MRM Health, MThera Pharma, MultiOmic Health, Murdoch University, MyBiotics Pharma, MySugarWatch DuoPack, Namocell, NAMUH, National Cerebral and Cardiovascular Disease Research Center, National Heart, Lung and Blood Institute, National Institute of Arthritis and Musculoskeletal Diseases, National Institute of Child Health and Human Development, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, National Organization for Rare Disorders, National Research Council Canada, National University of Singapore, Navidea Biopharmaceuticals, Nebraska Medicine, Nemaura Medical, Nemysis, Neogen, Neo Gene Pharm, Neomorph, NephroDI Therapeutics, Nestle Health Science, Neuraxpharm, NeuroBo Pharmaceuticals, Neurodon, NeuroFront, Newsoara Biopharma, New Wave Ventures, Neximmune, NGM Biopharmaceuticals, Nicoya, Nimbus Therapeutics, NIMIUM Therapeutics, NLC Pharma, Northwestern University, Novaremed, Novartis, Novasep, Novitium Pharma, Novo Integrated Sciences, Novo Nordisk, Nuformix, Numares, NutraFuels, Nutrition21, Ocean Spray Cranberries, Ohio State University, OliX Pharmaceuticals, Olympus, Omega Therapeutics, OmniaBio, One World Products, Open Book Extracts, OPKO Biologics, OPKO Health, Optithera, Optomed, Oramed Pharmaceuticals, Orchard Therapeutics, Oregon Health Sciences University, Orgenesis, Origin Agritech, OrphanPacific, OrsoBio, OSI Pharmaceuticals, Oslo University Hospital, Otsuka, Ovation, Pancryos, Pandion Therapeutics, Paraza Pharma, Particles for Humanity, Parvus Therapeutics, PathAI, Pathalys Pharma, Patia, Penn State Microbiome Center, PeptiDream, Performance Inspired Nutrition, PerkinElmer, Perspectum Diagnostics, Pfizer, PharmaCyte Biotech, Pharmanest, Pharmanovia, Pharmathen, Pharmavite, Phenex, Phillips-Medisize, PhoreMost, Phytolon, Piramal, Pliant Therapeutics, Pluristem Therapeutics, Polyganics, Population Health Partners, Precision Diabetes, Pressure BioSciences, Procyon Technologies, Profil Institute for Clinical Research, ProLynx, Promethera Biosciences, Provention Bio, Psyence Therapeutics, Purnovate, Quell Therapeutics, Quest Diagnostics, Radius Health, Rallybio, Rare Disease Company Coalition, Raziel Therapeutics, RC2, Readout Health, Reata Pharmaceuticals, Recordati, Redox, Redwire, Regenxbio, Regor Therapeutics, Relief Therapeutics, Remedium Bio, Renown Institute for Health Innovation, Resolution Therapeutics, Revive Therapeutics, Reyon Pharmaceuticals, Rezolute, Rho, Rimidi, Ripe Technology, Roche, Roche Diagnostics, SafeTraces, Sagimet Biosciences, Salix Pharmaceuticals, Sandhill One, Sanofi, Sanofi US Services, Sanwa Kagaku Kenkyusho, Science 37, Scientific Research Council, Scivita Medical Technology, Sciwind Biosciences, SCM Pharma, Seal Rock Therapeutics, Second Genome, Selecta Biosciences, Senda Biosciences, Senseonics, Senti Biosciences, Seoul National University, Seraxis, Sernova, SFC Fluidics, Shanghai Jiao Tong University, Shenzhen Chipscreen Biosciences, Shionogi Pharma, Siemens Healthineers, Sigilon Therapeutics, Silence Therapeutics, Singapore General Hospital, Sino Biopharmaceutical, Sirion Biotech, Sirona Biochem, SocialDiabetes, Solarea Bio, SomaLogic, SOOIL Development Company, Sookmyung Women's University, Sosei, Spark Therapeutics, Stealth BioTherapeutics, SteroTherapeutics, Stevanato, Sumitomo Dainippon Pharma, Summit Clinical Research, Sun Genomics, Surrozen, Suzhou Ribo Life Sciences, Synbiotech, Synbiotic Health, SynerK, Synlogic, Synspira, Synthetic Biologics, T-Cell Protect Hellas, Taisho Pharmaceutical, TaiwanJ Pharmaceuticals, Takara Bio, Takeda Pharmaceutical, Tandem Diabetes Care, Target RWE, Tate & Lyle, Taysha Gene Therapies, Teijin, Terns Pharmaceuticals, Terumo, TeselaGen, Tespo, Tetra Bio-Pharma, Tetris Pharma, Texas A&M University, The Healthy Aging Company, TheracosBio, Thorne HealthTech, Tianjin JuveStar Biotech, Tiburio Therapeutics, Tidepool, Tnuva Group, Todos Medical, Tolmar, Tome Biosciences, Tonghua Dongbao Pharma, TONIX Pharmaceuticals, Torrent Pharmaceuticals, Tottori University, TPMENA, TransThera, Trovita Health Science, True Diagnostics, TRx Biosciences, Twist Bioscience, UK Biobank, Ultragenyx Pharmaceuticals, Universe Pharmaceuticals, University Libre of Brussels, University of Alberta, University of British Columbia, University of California, San Diego, University of California, San Diego (UCSD) School of Medicine, University of California Irvine, University of California Los Angeles, University of California San Francisco, University of Chicago, University of Colorado, University of Edinburgh, University of Florida, University of Geneva, University of Maryland School of Medicine, University of Massachusetts, University of Miami, University of Nebraska, University of New Mexico, University of North Carolina, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Sheffield, University of Technology Sydney, University of Texas, University of Toronto, University of Virginia, University of Washington, University of West Indies, University of Wisconsin-Madison, University Paris Diderot, UP International, Upsher-Smith, USANA Health Science, UW Medicine, Valbiotis, Valley Oils Partners, Valo Health, Vanderbilt University, VELL Health, Ventus Therapeutics, Verantos, Veravas, Versiti Blood Research Institute, Vertex Pharmaceuticals, Vertice Pharma, Verve Therapeutics, VGI Health Technology, ViaCyte, Vifor Pharma, Viome, Vipergen, VIPUN Medical, Viralgen, Virginia Commonwealth University, Virginia Tech, Virtual Health Partners, VisionQuest Biomedical, Visirna Therapeutics, VistaGen Therapeutics, Vitro Biopharma, Vivet Therapeutics, Vivici, VOTIS Subdermal Imaging Technologies, vTv Therapeutics, Wake Forest University, Wake Forest University School of Medicine, Wanbang Biopharmaceuticals, Washington University in St Louis, WaVe Lifesciences, Weizmann Institute, WellDoc, WellGen, Willow Biosciences, Winhealth Pharma Group, W L Gore, XERIS Pharmaceuticals, Xlife Sciences, Xoma, XtalPi, Yale University, Yeda Research and Development Company, Yili Industrial Group, Ymir Genomics, Ypsomed, Yuhan Corporation, Zealand Pharma, Zelira Therapeutics, Zhejiang Hisun Pharmaceutical, ZyVersa Therapeutics

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.